Three isoforms of calcitonin (CT) exist in salmonids. Isohormones I and II are expressed in the pink salmon Oncorhynchus gorbuscha. We report here the existence in this species ofa CT gene and ofits transcripts, which encode for a fourth isohormone, the salmon CT (sCT) IV. This new CT gene was identified by PCR from genomic DNA and by sequencing the amplified DNA. The expression of this CT gene was established in ultimobranchial body and brain, by reverse transcription-PCR, hybridization and sequencing. The sCT IV gene, like the sCT I gene, is a complex transcription unit, containing exons encoding for a CT as a calcitonin generelated peptide (CGRP) molecule. The predicted peptide, sCT IV, has a greater homology with the eel CT and the sCT II than with the sCT I. Alignment of the sCT IV with other fish and chicken CT showed amino acid modifications in similar positions as those found during evolution. The predicted salmon CGRP IV peptide is highly homologous to the known CGRP molecules in other species, confirming the high conservation of the molecule during evolution. This identification of a new salmon CT gene is interesting both for the therapeutic potential represented by the new molecules encoded by this gene and for phylogenetic studies.
The calcitonin (CT) gene is a complex transcription unit encoding both the CT peptide and the calcitonin gene-related peptide (CGRP), which are produced by alternative splicing of the primary transcript (1) . Identical organization was established in rat, human, chicken, and salmon species (1) (2) (3) (4) (5) . Existence of a second CT gene was then demonstrated in rat and human (6, 7) . However, in these two studied species, only the gene I encodes for a CT molecule, the gene II being unproductive for the CT peptide.
Study of the CT genes in a nonmammalian vertebrate, the salmonid species, is particularly interesting, as in this species, three isohormones of CT have been identified (8) , and, paradoxically, two of them are the most biologically active molecules in mammals (9) . So far, only the gene encoding for the isohormone I has been characterized. The nucleotide sequence of the salmon CT (sCT) I cDNA was primarily established (10) , and, recently, genomic DNA analysis re- vealed that a CGRP molecule can also be encoded by the same gene (5) , as in mammalian vertebrates. Existence in salmon of such a complex transcription unit coding for the sCT I allowed us to speculate that similar genes coding for the other sCT isohormones might exist, and so other salmon CGRP (sCGRP) molecules could also occur in that species.
In view of identifying these CT gene sequences, we pursued our studies on salmon genomic DNA. We were encouraged in this search by the fact that during identification of the sCT I/sCGRP I gene in salmon DNA (5) , evidence was obtained for the existence of other CT/CGRP genes. These researches led us to identify a new CT gene in salmon. This gene both encodes for a CT and a CGRP molecule, whose sequences had not yet been elucidated. We further looked for expression of these two molecules in salmon tissues. Comparison of their deduced amino acid sequences with those of other vertebrates provides a new insight in evolution of the CT gene family and supports biological interest of these new CT and CGRP molecules.
MATERIALS AND METHODS
Experimental Procedures. Genomic DNA of salmon testes (Oncorhynchus keta) was purchased from Pharmacia (product no. 27-4564, lot no. BJ 4564101).
Fresh tissues were collected from male and female pink salmon (Oncorhynchus gorbuscha) during an expedition to Alert Bay at the north end of Vancouver Island, British Columbia. After netting, the fish were immediately killed by a sharp blow to the head and ultimobranchial bodies (UBs) and brains were removed, frozen in liquid nitrogen, and stored at -800C.
RNA Extraction from Tissues. Total RNA was extracted from UBs and brain tissues by a single-step extraction with guanidinium thiocyanate and phenol/chloroform (11) . They were quantified using an OD of 260 nm and stored at -80°C.
PCR Amplification of Genomic DNA and DNA Fragments Analysis. In previous study (5) , during identification of the sCT I/sCGRP I gene using direct and inverse PCR amplification and universal primers, evidence was obtained for the existence of a second sCT gene (called sCT IV gene) in salmon DNA. Based on a provisional sequence of this gene, we were able to construct specific primers for PCR amplification of regions encoding sCT IV and sCGRP IV peptides, respectively (Table  1) . PCR was performed essentially as described by Saiki et al. (12) . The thermal profile was as follows: denaturation for 1 min at 94°C, annealing for 2 min at 55°C, and extension for 30 sec at 72°C, for 40 cycles. After electrophoresis of the amplified products, DNA fragments of the expected length was extracted from 3% Nusieve agarose gel (FMC), cleaved by BamHI, and cloned in M13 mp8 as described (5) . DNAs from at least 10 clear plaques were sequenced by the dideoxy chain termination method (13) 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Subsequently, to demonstrate that the two amplified CT and CGRP molecules belong to the same gene, a PCR amplification using the primer set 9145/9148 (Table 1) was performed as described (5) . The amplified DNA fragments were then cloned and sequenced from both ends as described above.
Reverse Transcription-PCR (RT-PCR) Amplification of UB and Brain mRNA. UB and brain mRNAs were transcribed to cDNAs with Moloney murine leukemia virus reverse transcriptase (BRL) and a synthetic primer, the poly(dT)17 box primer [oligonucleotide (oligo) 42; Table 2 ]. Then, the firststrand cDNAs was amplified using Taq polymerase (Eurobio, Paris), a 3' primer identical to the end of the poly(dT) box primer (oligo 41; Table 2 ) and a 5' primer specific for exon 4 of the sCT IV genomic sequence chosen upstream of the CT coding sequence (oligo S'4; Table 2 ). A second PCR amplification was performed using the same 5' primer and a 3' primer specific for exon 4 of the sCT IV genomic sequence situated downstream to the CT coding sequence (oligo S4; Table 2 ). A similar protocol was used to establish expression of sCGRP IV molecules in UB and brain tissues. In that case, cDNAs were amplified using primarily a 5' primer specific for the first bases of the sCGRP IV genomic sequence (oligo CG'4; Table 2 ) and the 3' primer, oligo 41 ( Table 2 ). The second PCR was performed with the previous 5' primer (oligo CG'4) and a 3' primer specific for the end of the exon 5 genomic sequence (oligo CG4; Table 2 ).
Adequate controls were included, and they consisted of samples with RNase treatment or without the reverse transcriptase step. The amplification conditions were as follows: denaturation for 1 min at 94°C, annealing for 1 min at 55°C, and further extension for 1 min at 72°C, for 30 cycles in a thermal cycler. Purified PCR primers were purchased from Genosys (United Kingdom).
Southern Analysis. The above PCR amplification products were run on either a 1.3% or a 2% agarose gel. Size estimations were deduced from DNA molecular mass marker (Boehringer Mannheim). Blotting onto a Gene-screen membrane (NEN) of the PCR products was achieved as described (14) . The Genescreen membrane with the transferred PCR products obtained sequence of mRNA and an additive sequence, the box sequence.
Oligo 41 was homologous to the box sequence of oligo 42. Oligos S'4 and S4 were a set of primers specific for exon 4 of sCTIV gene, while the set of oligos CG'4 and CG4 was specific for exon 5 . Oligo SR, used as a probe, was specific for exon 4 of sCT I mRNA sequence and crosshybridized with exon 4 of sCT IV sequence.
after RT-PCR amplification with specific primers of sCT IV was hybridized with a radiolabeled oligo probe corresponding to the first 21 nt of the sCT I sequence, which cross-hybridized with the corresponding region of the sCT IV sequence (oligo SR; Table 2 ). Oligo probe was end-labeled with [32P]-ATP (NEN) and T4 kinase (BRL). Hybridizations of the Gene-screen membranes were performed as described (14) .
Sequence Analysis of the RT-PCR Fragments. PCR products obtained after RT-PCR amplification of UB mRNA with specific primers of sCT IV (oligo S'4 and oligo 41) were subcloned into a plasmid vector using the TA cloning system (Invitrogen) according to the manufacturer's instructions. Plasmid DNAs were sequenced by the dideoxy nucleotide termination method (13) using the dsDNA cycle sequencing system as described by the supplier (GIBCO/BRL) and 33P-labeled forward primer of the vector as sequencing primer. A direct sequence analysis of the PCR product was also performed to circumvent Taq polymerase error. For that, the DNA fragment obtained after the second round of PCR (primers set S'4 and S4, Table 2 ) was preliminarily fractionated on agarose, extracted using the QIAEX kit (Qiagen, Chatsworth, CA), and sequenced.
PCR products obtained after amplification of brain cDNA with specific sCGRP IV primers were subjected to the same protocols as described above, except that only DNA fragments corresponding to the second round of PCR (primer set: G'4, G4) were used in that case.
Alignment of the Nucleotide Sequences of sCT IV and sCGRP IV with Those of sCT I and sCGRP I. Homology studies between the sCT IV and sCT I nucleotide sequences were carried out according to the method of Kanehisa (15) using standard parameters. Similar studies were performed for the sCGRP IV and CGRP I molecules.
Comparison of the sCT IV and sCGRP IV Amino Acid Sequences with Those of Other Vertebrates. The amino acid sequences translated from the nucleotide sequences were compared with those of other vertebrates using the alignment program of protein sequence (15) .
Phylogenetic Study. A phylogenetic analysis was performed with all the known CT amino acid sequences.
RESULTS
Identification of a New CT Gene by PCR Amplification of Genomic DNA and Sequence Analysis. PCR amplification using sCT IV specific primers 9145/9146 and salmon genomic DNA as template produced a DNA fragment whose deduced amino acid sequence corresponded to a typical CT peptide (Fig. 1A) . The 32-aa CT peptide was located between the cleavage site, Lys-Arg, and the cleavage-amidation sites, GlyLys-Lys-Arg, as in all known CT precursors. A 5-aa difference was observed between this peptide and the sCT I peptide. These amino acid modifications were situated in positions 15, 22, 26, 27 , and 29. In addition, some rare silent modifications in nucleotides were also noted in the sCT coding sequence (Fig. 1A) .
With the sCGRP specific primers 9147 and 9148, a DNA fragment encoding a CGRP molecule was obtained (Fig. 1B) . The 37-aa CGRP peptide was between a Lys-Arg cleavage site and a Gly-Arg-Arg-Arg-Arg cleavage-amidation site as in other CGRP precursors. Many nucleotide variations were observed between the sCGRP IV and the sCGRP I sequences, all of which were silent at the amino acid level, except for the one in position 17. The 3' coding sequence of exon 5, situated downstream to the CGRP sequence, was 4 aa smaller than that of the sCGRP I (Fig. 1B) us to obtain nucleotide sequences that exactly matched with the sCT and sCGRP sequences presented in Fig. 1 A and B, respectively. This result permitted the conclusion that the two sequences belong to one gene. This conclusion was supported by the fact that the distance between these two sequences in salmon DNA (-1100 bp) was similar to the distance in human DNA (1300 bp). In analogy with the known CT/CGRP genes, the available evidence suggested that the sequences in A and B in Fig. 1 represented exon 4 , encoding sCT IV, and exon 5, encoding sCGRP IV, respectively, of this gene.
Identification in UB and Brain of sCT IV and sCGRP IV mRNA by RT-PCR. After PCR amplification of cDNA, obtained by reverse transcription of UB and brain RNAs with a 5' primer specific for sCT IV and a 3' oligo d(T)17 box primer, two DNA fragments were obtained for each tissue (Fig. 24) . Hybridization to the SR oligo probe allowed to identify the DNA band of the lower size, "600 bp, as the specific amplified PCR product (Fig. 2B ). Table 2 ) and a 3' primer corresponding to the end of the poly(dT) box primer (oligo 41; Table 2 The second round of PCR, using the same 5' primer and a 3' primer specific for sCT IV, provided DNA fragments of the expected size, 200 bp, which also hybridized to the aforementioned SR oligo probe (Fig. 3 A and B) . These results highly suggested presence of RNA coding for sCT IV in salmon UB and brain. Identity of the amplified DNA fragment with the sCT IV genomic sequence was confirmed by sequencing. In the terminal peptide, situated after the cleavage amidation site, a difference with the genomic sequence of 1 nt (A instead of G) was noted in the first amino acid, inducing change of Gly to Ser.
Similarly, amplification of UB and brain cDNA, primarily with a 5' primer specific for the sCGRP IV genomic sequence and a 3' primer corresponding to the oligo d(T)17 box primer, and subsequently with an internal 3' primer, oligo CG4, resulted in a DNA fragment of "150 bp for each tissue (Fig.  4) . This fragment corresponded to the anticipated size and so was in favor of the presence of RNA coding for the sCGRP IV in the tested tissues. As PCR-amplified product was detected on agarose gel only after the second round of PCR, sequence was established on that DNA fragment. These results established that mRNAs coding for sCT IV and sCGRP IV were present in the salmon tissues, UB, and brain. Table 2 ) and a 3' primer corresponding to the end of the poly(dT) box primer (oligo 41; Table 2 ) were used. No DNA fragment was UV detectable in these conditions (data not shown). A second round of amplification was performed from these PCR products using a 3' primer, an internal oligo specific for CGRP IV (oligo CG4; Table  2 ), and the same 5' primer as that in the first round. In that case, two DNA fragments of the expected size ("150 bp) were observed (lanes 2 and 3), which were subsequently submitted to sequencing. Lane 1, PCR control; and lane 4, size marker.
Alignment and Comparison of sCT IV Amino Acid Sequence with the Established CT Amino Acid Sequences. Comparison of the sCT IV amino acid sequence with those of the other salmon isohormones indicated a difference of 5 aa with CT I, 3 aa with CT II, and 4 aa with the CT III. Extension of the comparison with amino acid sequences of the other nonmammalian vertebrates showed that a greater homology exists with the eel CT sequence than with the other sCT and, to a lesser extent, with the chicken CT, as they differed by 2 and 4 aa, respectively (Fig. 5) . We must note that the 2-aa difference between the sCT IV and eel CT corresponded to amino acids in position 15 and 22. These two, modified in sCT I, are also found in sCT II and sCT III.
Comparison of sCGRP IV Amino Acid Sequence with the Other Known CGRP Amino Acid Sequences. Alignment of the different CGRP amino acid sequences indicated that sCGRP IV differed by 1 aa with the sCGRP I and by 4 aa with the chicken CGRP. Comparison of sCGRP IV with the human molecules showed a greater homology between the sCGRP IV molecule and the human CGRP II molecule than between the sCGRP I molecule and the human CGRP II molecule (Fig. 6) .
Phylogenetic Analysis. The phylogenetic tree confirmed evolutionary proximity of the sCT IV molecule with the eel CT molecule and, to a lesser extent, with the chicken molecule (Fig. 7) .
DISCUSSION
We have identified in salmon genomic DNA of 0. keta a new CT gene encoding both for CT and CGRP molecules and demonstrated that this gene is transcribed in salmon tissues, UB, and brain of the pink salmon 0. gorbuscha. So, it appears that in salmon, the two transcription units further identified both encoded CT and CGRP molecules, contrary to those found in human species, where only the gene I can generate CT transcripts, the gene II being a pseudogene for human CT. It remains to be established whether the transcription units coding for the sCT II and sCT III also coded for two CGRP molecules.
Up until now, three isohormones of CT have been reported for the different salmon species studied: sCT I, sCT II, and sCT III. Pink salmon, like sockeye and chum salmon, do possess sCT I and sCT II, while coho has sCT II and sCT III (8) . Our results established that the pink salmon, 0. gorbuscha, could express, in addition to sCT I and sCT II, another isohormone, the sCT IV. Comparison of the predicted sCT IV amino acid sequence with those of the other bony fish CT, confirmed the high susceptibility to modification of the amino acids situated in positions 15 and 22 and also in positions 26, 27, and 29. A majority of these modifications are maintained with evolution, as they are also found in another nonmammalian species, the chicken. Comparison with a cartilaginous fish, the ray species, shows a low degree of homology between the CT amino acid sequences. This divergence seems to appear concomitantly with the emergence of a calcified skeleton.
To date, in human species, only one CT molecule has been shown to be expressed, and a lower vertebrate CT-like molecule has been suggested (24) . In salmon fish, the situation is very different, as three molecules of CT have been observed (8) , and we have established the possible expression of a fourth one. Existence of multiple isoforms of CT in salmonids may be explained by the genomic tetraploidization event they underwent, leading to the presence of extensive gene duplication, and also by the persistence during evolution of a productive CT sequence. In addition to the presence of such multiple isoforms in salmon, we recently reported that different mRNA pathways may be used to produce the sCT I molecule (25) . These differences between human and salmon species are in favor of an important physiological role for the peptide in salmon species, a role that would have disappeared during evolution. The higher biological activity of the salmon molecule compared with that of mammals (9) is consistent with this hypothesis. We and others previously reported important variations of CT during the salmon migration and suggested a role for the peptide during reproduction (14, 26) . A CT action on plasma calcium concentration of fishes has been highly suggested, but to date, no consensus has arisen about CT effect on calcemia (27) (28) (29) . We recently established that, in addition to its endocrine action, CT can exert a paracrine or autocrine role in the gill of these salmon species (30) , and so, may locally perform an important action in calcium regulation, as suggested by early in vitro experiments (31) .
Amino acid sequence analysis of the sCGRP IV indicates that the molecule has a greater homology with the chicken CGRP sequence than has the sCGRP I molecule. Comparison with CGRP amino acid sequences of higher vertebrates showed a somewhat greater homology with the human CGRP II. The small variations observed in the sequences of the CGRP molecules between salmon fishes and mammalian species imply important conservation of the molecule during evolution and are consistent with the physiological importance of the peptide.
We previously demonstrated existence of sCGRP mRNA in salmon tissues (32) . By PCR, we established that a mRNA population coding for the sCGRP IV molecule is expressed in brain tissue, as is the case for the CGRP I molecule (data not shown). Identification of CGRP-like molecules in fish brain has been previously reported (32, 33) . Such a localization of the peptide suggests that, as in mammals, CGRP can exert a neuropeptide role in fish.
Moreover, our study indicates that the sCT IV peptide can potentially be expressed in UB and brain. Though we don't quantify expression of the two peptides in tissues, efficiency of amplification of the sCT IV in UB and brain is in favor of a tissue-specific expression of the peptides, as it occurs in mammals (1) .
The similarity of this new sCT with the highly biologically active eel CT and sCT II (9) allows to anticipate for an important activity of the sCT IV and thus prompts us to further investigate the activity of the peptide. This will represent the next step of this work, and it will involve biological studies and also characterization of the sCT IV receptors. Similarly, it would be important to compare activity of sCGRP IV to that of human CGRP for clinical applications.
In conclusion, the identification of a new sCT gene is highly important, as it may yield information on the evolution of the CT gene family, and also because of potential therapeutic interest in the new CT' and CGRP molecules encoded by this gene.
